<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement is one of the hallmarks underlying poor prognosis in SLE and for therapeutic strategies it is difficult to assess which patients are at risk </plain></SENT>
<SENT sid="1" pm="."><plain>As detectability of cerebral microembolic signals (<z:chebi fb="28" ids="39005,39010">MES</z:chebi>) using long-term transcranial Doppler ultrasonography (TCD) proved to be predictive of past and future <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in patients with carotid <z:mp ids='MP_0006135'>artery stenosis</z:mp>, we investigated whether <z:chebi fb="28" ids="39005,39010">MES</z:chebi> might be similarly useful in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>Our study population consisted of 46 SLE patients and five with primary APS (pAPS) </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve of the 46 patients with SLE, 10 of them with secondary APS (sAPS), and four of five patients with pAPS had a history of cerebrovascular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> (CVI) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="28" ids="39005,39010">MES</z:chebi> in the middle cerebral artery were detected in 14 of 16 patients with and in one of 35 without CVI (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL) were positive in 12 of 15 patients with and 18 of 36 without <z:chebi fb="28" ids="39005,39010">MES</z:chebi>, and the rate of <z:chebi fb="28" ids="39005,39010">MES</z:chebi> correlated to the titre of aPL </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="28" ids="39005,39010">MES</z:chebi> from APS patients resembled in their energy distribution those from patients with symptomatic <z:e sem="disease" ids="C0741975" disease_type="Disease or Syndrome" abbrv="">carotid disease</z:e> and were significantly different from those associated with artificial heart valves </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, cerebral <z:chebi fb="28" ids="39005,39010">MES</z:chebi> are detectable in APS patients and correlate with a history of CVI </plain></SENT>
<SENT sid="8" pm="."><plain>Whether this innovative method may provide individual risk assessment in APS patients has to be addressed in prospective studies </plain></SENT>
</text></document>